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Abstract 70 
An epidemiological paradox surrounds Salmonella enterica serovar Enteritidis. In 71 
high-income settings, it has been responsible for an epidemic of poultry-associated, 72 
self-limiting enterocolitis, whilst in sub-Saharan Africa it is a major cause of invasive 73 
nontyphoidal Salmonella disease, associated with high case-fatality. Whole-genome 74 
sequence analysis of 675 isolates of S. Enteritidis from 45 countries reveals the 75 
existence of a global epidemic clade and two novel clades of S. Enteritidis that are 76 
each geographically restricted to distinct regions of Africa. The African isolates 77 
display genomic degradation, a novel prophage repertoire and have an expanded, 78 
multidrug resistance plasmid. S. Enteritidis is a further example of a Salmonella 79 
serotype that displays niche plasticity, with distinct clades that enable it to become a 80 
prominent cause of gastroenteritis in association with the industrial production of 81 
eggs, and of multidrug resistant, bloodstream invasive infection in Africa.  82 
  83 
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Introduction 84 
 85 
Salmonella enterica serovar Enteritidis (hereafter referred to as S. Enteritidis) has 86 
been a global cause of major epidemics of enterocolitis, which have been strongly 87 
associated with intensive poultry farming and egg production1. The serovar is 88 
usually considered to be a generalist in terms of host range and has a low human 89 
invasiveness index, typically causing self-limiting enterocolitis2. Following a number 90 
of interventions in the farming industry involving both improved hygiene and 91 
poultry vaccination, epidemic S. Enteritidis has been in decline in many countries 92 
including the United Kingdom and USA3,4. S. Enteritidis has also been used 93 
extensively since the early 1900s as a rodenticide (named the “Danysz virus”), 94 
following development at Institut Pasteur, France. Although by the 1960s, 95 
Salmonella-based rodenticides had been banned in the US, Germany and the UK, S. 96 
Enteritidis is still produced as a rodenticide in Cuba, under the name Biorat®5. 97 
 98 
Serovars of Salmonella that cause enterocolitis in industrialised settings are strongly 99 
associated with life-threatening invasive nontyphoidal Salmonella (iNTS) disease in 100 
sub-Saharan Africa (SSA). S. Enteritidis and Salmonella enterica serovar 101 
Typhimurium (S. Typhimurium) are the two leading causes of iNTS disease in SSA6 102 
and both are associated with multidrug resistance (MDR)7. The clinical syndrome 103 
iNTS disease is associated with immunosuppression in the human host, particularly 104 
malnutrition, severe malaria and advanced HIV in young children and advanced HIV 105 
in adults8. It has been estimated to cause 681,000 deaths per year9.  106 
 107 
Salmonella is a key example of a bacterial genus in which there is a recognizable 108 
genomic signature that distinguishes between a gastrointestinal and an extra-109 
intestinal/invasive lifestyle10, whereby functions required for escalating growth in 110 
an inflamed gut are lost when the lineage becomes invasive11. In order to investigate 111 
whether there were distinct bacterial characteristics explaining the very different 112 
epidemiological and clinical profile of epidemic isolates of serotype S. Typhimurium 113 
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from SSA and industrialised settings, whole-genome sequence (WGS) investigations 114 
of this serovar were previously undertaken. These revealed a novel pathotype of 115 
multilocus sequence type (MLST) ST313 from SSA, which differed from clades that 116 
cause enterocolitis in industrialised settings, by showing patterns of genomic 117 
degradation potentially associated with more invasive disease and differential host 118 
adaptation12-17. 119 
 120 
In relation to S. Enteritidis, there is a growing body of literature on the evolutionary 121 
history, phylogeny and utility of WGS for surveillance of S. Enteritidis outbreaks18-20. 122 
The broadest study of the phylogeny to date revealed five major lineages, but 123 
contained only two African isolates21. There have also been limited reports of 124 
isolates of S. Enteritidis from African patients living in Europe that are MDR and 125 
which display a distinct phage type (PT 42)22,23. We therefore hypothesized that 126 
there are distinct lineages of S. Enteritidis circulating in both the industrialised and 127 
developing world with different origins, likely distinct routes of spread and that are 128 
associated with different patterns of disease, which will display the distinct genomic 129 
signatures characteristic of differential adaptation. To investigate this we have 130 
collected a highly diverse global collection of S. Enteritidis isolates and compared 131 
them using whole-genome sequencing, the highest possible resolution typing 132 
methodology. 133 
 134 
 135 
 136 
 137 
 138 
 139 
 140 
  141 
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Results 142 
 143 
Isolate collection 144 
 145 
In total, 675 isolates of S. Enteritidis isolated between 1948 and 2013 were 146 
sequenced. The collection originated from 45 countries and six continents (Table 1). 147 
496/675 isolates were from Africa, with 131 from the Republic of South Africa 148 
(RSA), a further 353 from the rest of SSA, and 12 from North Africa (Table 1). There 149 
were 343 isolates from normally sterile human sites (invasive), 124 non-invasive 150 
human isolates (predominantly stool samples) and 40 from animal, food or 151 
environmental sources. The full metadata are described in Supplementary Table 1 152 
and have been uploaded to the publically available database Enterobase. 153 
 154 
Phylogeny  155 
 156 
675 S. Enteritidis genomes and one Salmonella enterica serovar Gallinarum were 157 
mapped to the S. Enteritidis strain P125109 reference sequence, variable regions 158 
excluded and the remaining sites were screened for single nucleotide 159 
polymorphisms (SNPs). This left an alignment containing a total of 42,373 variable 160 
sites, from which a maximum likelihood (ML)-phylogeny was constructed using S. 161 
Gallinarum, which is a closely related serovar, as an out-group (Figure 1). HierBAPS 162 
was run over two rounds, which provided clear distinction between 163 
clades/clusters24. The phylogeny of S. Enteritidis revealed evidence of three clades 164 
associated with epidemics, one which we have termed the ‘global epidemic clade’ 165 
and includes the reference PT4 isolate P125109 and two African clades: one 166 
predominantly composed of West African isolates (labeled the ‘West African clade’) 167 
and a second composed of isolates predominantly originating in Central and Eastern 168 
Africa, called the ‘Central/Eastern African clade’). Figure 1 also shows the other 169 
clades and clusters predicted by HierBAPS, the largest of which is a paraphyletic 170 
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cluster from which the global epidemic clade emerged (Outlier Cluster in Figure 1), 171 
and a further five smaller clades or clusters predicted by HierBAPS. 172 
 173 
The global epidemic clade contains isolates of multiple phage types, including 4 and 174 
1, which have been linked to the global epidemic of poultry associated human 175 
enterocolitis25. It comprised 250 isolates from 28 countries, including 43 from 176 
Malawi and 82 from RSA. They were isolated from across a 63-year period (1948-177 
2013). Antimicrobial susceptibility testing had been performed on 144 isolates and 178 
104 were susceptible to all antimicrobials tested, five were multidrug resistant 179 
(MDR: resistant to 3 or more antimicrobial classes), one was nalidixic acid resistant 180 
and none were extended-spectrum beta-lactamase (ESBL)-producing isolates. 181 
Database comparison of the genomes from this clade revealed that 221 (88%) of 182 
them contained no predicted antimicrobial resistance (AMR) genes apart from the 183 
cryptic resistance gene aac(6')-Iy26. 184 
 185 
The global epidemic clade has emerged from a diverse cluster previously described 186 
by Zheng27, which encompassed 131 isolates (Figure 1: ‘Outlier Cluster’). In addition 187 
to being paraphyletic, this group was geographically and temporally diverse, and 188 
predominantly drug susceptible (59/71 isolates). Whilst the majority of the 189 
diversity of phage typed isolates was contained within the global epidemic clade, 190 
this cluster alone contained isolates of phage type 14b, which was recently 191 
associated with a multi-country outbreak of S. Enteritidis enterocolitis in Europe 192 
associated with chicken eggs from Germany28. There were also 41 isolates from RSA 193 
in this clade, where it has been a common cause of bloodstream infection, and 39 194 
bloodstream isolates from Malawi. Database comparison of the genomes from this 195 
clade revealed that 122 (82%) of these genomes contained no predicted AMR genes 196 
apart from the cryptic resistance gene aac(6')-Iy. 197 
 198 
There were two related, but phylogenetically and geographically distinct, epidemic 199 
clades that largely originated from SSA. The Central/Eastern African clade included 200 
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166 isolates, all but two of which (from RSA) came from this region. Of these, 201 
126/155 (82%) were MDR and 148/153 (97%) displayed phenotypic resistance to 202 
between one and four antimicrobial classes. All of these genomes contained at least 203 
five predicted resistance genes and 128 (77%) contained nine (Table 2 and 204 
Supplementary Table 2). 155/165 (94%) of these isolates were cultured from a 205 
normally sterile compartment of a human (i.e. blood or cerebrospinal fluid) and 206 
were considered to be causing invasive disease (Table 2). The second African 207 
epidemic clade was significantly associated with West Africa with 65/66 isolates 208 
coming from this region and one isolate from USA. This clade was also associated 209 
with drug resistance (62 [94%] resistant to ≥1 antimicrobial class by phenotype and 210 
genotype) and human invasive disease (61 [92%]). It also included two isolates that 211 
were subtyped as phage type 4. 212 
 213 
The remaining 58 isolates included in this study were extremely diverse, 214 
phylogenetically, temporally and geographically. Only two displayed any phenotypic 215 
AMR, one of which was MDR. Inspection of the genome revealed that five had 216 
predicted AMR genes in addition to aac(6')-Iy, four of which were isolated in sub-217 
Saharan Africa. Twenty were associated with invasive human disease, and six were 218 
recovered from stool. Three isolates were from stocks of rodenticide and these were 219 
phylogenetically remote from both global-epidemic and the two African epidemic 220 
clades.  221 
 222 
To add further context to these findings we screened the entire publically available 223 
Public Health England (PHE) sequenced Salmonella routine surveillance collection, 224 
which includes 2,986 S. Enteritidis genomes, 265 of which were associated with 225 
travel to Africa (Supplementary Figure 1). Within this huge collection, including 61 226 
(2.0%) bloodstream isolates and 2670 (89.4%) stool isolates, only 6 isolates (4 from 227 
blood culture, 1 from stool) fell within to the West African clade and 1 (from stool) 228 
belonged to the Central/Eastern African clade. Notably, these isolates were all either 229 
associated with travel to Africa and/or taken from patients of African origin.  230 
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It is apparent from the location of the archetypal reference isolate and archetypal 231 
phage types in the phylogeny (Supplementary Figure 2) that the majority of S. 232 
Enteritidis studied previously belonged to the global epidemic clade associated with 233 
enterocolitis in industrialised countries. Furthermore, its also clear that two 234 
additional, previously unrecognized S. Enteritidis lineages have emerged, largely 235 
restricted to Africa, that are strongly associated with MDR and invasive disease.  236 
 237 
To understand how recently these Africa-associated lineages emerged we used 238 
Bayesian Evolutionary Analysis by Sampling Trees (BEAST) to reconstruct the 239 
temporal history of the epidemic clades29. These data (Supplementary Figure 3) 240 
estimate the most recent common ancestor (MRCA) of the Central/Eastern African 241 
clade dates to 1945 (95% Credible Interval [CrI]: 1924-1951) and for the West 242 
African clade it was 1933 (95% CrI: 1901-1956). We estimate the MRCA of the 243 
global epidemic clade originated around 1918 (95% CrI: 1879-1942 – 244 
Supplementary Figure 4), with a modern expansion occurring in 1976 (95% CrI: 245 
1968-1983), whereas the paraphyletic cluster from which it emerged dates to 246 
approximately 1711 (95% CrI: 1420-1868). 247 
 248 
Contribution of the accessory genome  249 
 250 
Prophages have the potential to carry non-essential "cargo" genes, which suggests 251 
they confer a level of specialization to their host bacterial species, whilst plasmids 252 
may confer a diverse array of virulence factors and AMR 30,31. Therefore it is critical 253 
to evaluate the accessory genome in parallel with the core. 622 sequenced genomes 254 
were used to determine a pangenome, which yielded a core genome comprising 255 
4,076 predicted genes present in ≥90% isolates, including all 12 recognised 256 
Salmonella Pathogenicity Islands as well as all 13 fimbrial operons found in the 257 
P125109 reference32. The core gene definition was set to minimize stochastic loss of 258 
genes from the core due to errors in individual assemblies across such a large 259 
dataset. The accessory genome consisted of 14,015 predicted genes. Of the 260 
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accessory genes, 324 were highly conserved across the global and two African 261 
epidemic clades, as well as the outlier cluster. Almost all were associated with the 262 
acquisition or loss of mobile genetic elements (MGEs) such as prophage or plasmids. 263 
Prophage regions have been shown to be stable in Salmonella genomes and are 264 
potential molecular markers, the presence of which has previously been used to 265 
distinguish specific clades13,33. 266 
 267 
The lineage-specific whole gene differences of the major clades are summarized in 268 
Figure 2 and plotted against the representatives of the four major clades in 269 
Supplementary Figure 5. The lineage specific sequence regions include 57 predicted 270 
genes found to be unique to the global epidemic clade (Figure 2), all of which were 271 
associated with prophage ϕSE20, a region shown to be essential for invasion of 272 
chicken ova and mice in one previous study34. There were a further 39 genes 273 
conserved in the global epidemic and the paraphyletic outlying cluster, which were 274 
absent from both African clades, 26 of which correspond to region of difference 275 
(ROD) 2132. The Central/Eastern Africa clade contained 77 predicted genes that 276 
were absent in the other clades. 33 were associated with the virulence plasmid and 277 
a further 40 chromosomal genes were associated with a novel, Fels-2 like prophage 278 
region (φfels-BT). The West African clade had only 15 distinct predicted genes, 11 of 279 
which were plasmid-associated. The two African clades shared a further 102 genes: 280 
48, including a leucine-rich repeat region, were associated with a novel prophage 281 
region closely related to Enterobacter phage P88, 44 were associated with a Gifsy-1 282 
prophage found in S. Bovismorbificans and eight were associated with a Gifsy-2 283 
prophage which has degenerated in the reference P125109.  284 
 285 
The S. Enteritidis plasmid is the smallest of the generic Salmonella virulence 286 
plasmids at 58 kb and is unusual in that it contains an incomplete set of tra genes 287 
that are responsible for conjugative gene transfer. The phylogeny of the S. 288 
Enteritidis virulence plasmid backbone was reconstructed using reads that mapped 289 
to the S. Enteritidis reference virulence plasmid, pSENV. 120/675 (18%) genomes 290 
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lacked pSENV. The virulence plasmid phylogeny is similar to that of the 291 
chromosome, suggesting that they have been stably maintained by each lineage and 292 
diversified alongside them (Supplementary Figure 6).  293 
 294 
The virulence plasmids from the African clades were much larger than those held in 295 
the other clades at ~90 kb. A representative example was extracted from Malawian 296 
isolate D7795, sequenced using long read technology to accurately reconstruct it 297 
(PacBio; see methods) and denoted pSEN-BT (Accession number LN879484). pSEN-298 
BT is composed of a backbone of pSENV with additional regions that are highly 299 
similar to recently sequenced fragments of an novel S. Enteritidis virulence plasmid 300 
(pUO-SeVR) isolated from an African patient presenting with MDR invasive S. 301 
Enteritidis in Spain22. Plasmid pSEN-BT harbours nine AMR genes (full list in 302 
Supplementary Table 2), plus additional genes associated with virulence and a 303 
toxin/antitoxin plasmid addiction system. Of note, plasmids from the West African 304 
isolates carry resistance gene chloramphenicol acetyl transferase A1 (catA1), 305 
whereas the Central/Eastern African strains carry catA2 and tetracycline resistance 306 
gene tet(A). Like pSENV, the African virulence plasmid contained an incomplete set 307 
of tra genes and so is not self-transmissible. This was confirmed by conjugation 308 
experiments and is consistent with previous reports22,23. These observations 309 
suggest that the evolution of the S. Enteritidis plasmid mirrors that of the 310 
chromosome; it is thus not a ‘novel’ plasmid, but in different SSA locations has 311 
acquired different AMR genes. 312 
 313 
Multiple signatures of differential host adaptation 314 
 315 
It has been observed in multiple serovars of Salmonella including S. Typhi, S. 316 
Gallinarum and S. Typhimurium ST313 that the degradation of genes necessary for 317 
the utilization of inflammation-derived nutrients is a marker of that lineage having 318 
moved from an intestinal to a more invasive lifestyle13,14,32,35. Accordingly, we have 319 
looked for similar evidence within a representative example of a MDR, invasive, 320 
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Central/Eastern African clade isolate, D7795, that was isolated from the blood of a 321 
Malawian child in 2000. The draft genome sequence of D7795 closely resembles 322 
that of P125109, however, in addition to the novel prophage repertoire and plasmid 323 
genes described above, it harbours a number of predicted pseudogenes or 324 
hypothetically disrupted genes (HDGs)11.  325 
 326 
In total, there were 42 putative HDGs in D7795, many of which are found in genes 327 
involved in gut colonisation and fecal shedding as well as various metabolic 328 
processes such as cobalamine biosynthesis which is a cofactor for anaerobic 329 
catabolism of inflammation-derived nutrients, such as ethanolamine, following 330 
infection36. Curation of the SNPs and insertions or deletions (indels) predicted to be 331 
responsible for pseudogenisation across the Central/Eastern African clade and West 332 
African clade revealed 37/42 predicted HDGs were fixed in other representatives of 333 
the Central/East African clade, with 27 of them being present in over 90% of 334 
isolates from that clade. Relatively fewer HDGs in D7795 (19/42) were present in 335 
representatives of the West African clade, although 13 were present in ≥90% of 336 
isolates (Supplementary Table 3).   337 
 338 
In addition to this evidence of reductive evolution in D7795, there were 363 genes 339 
containing non-synonymous (NS)-SNPs, which change the amino acid sequence and 340 
so may have functional consequences37. The two African clades were screened for 341 
the presence of these NS-SNPs and 131 were found to be present and completely 342 
conserved across both clades, including NS-SNPs in 43 genes encoding predicted 343 
membrane proteins, 36 metabolic genes and 23 conserved hypothetical genes 344 
(Supplementary Table 4). Furthermore many of these NS-SNPs fall in genes within 345 
the same metabolic pathways as the HDGs (see Supplementary Note for detailed 346 
description).  Supplementary Table 5 provides a list of some of the common traits 347 
identified amongst the functions of genes lost independently by D7795, S. Typhi and 348 
S. Gallinarum. The disproportionate clustering of mutations in membrane structures 349 
13 
 
observed in the African clades is yet another sign of differential host adaptation 350 
analogous to that reported in both S. Typhi35 and S. Gallinarum32.  351 
 352 
BiologTM growth substrate platform profiling 353 
 354 
The BiologTM platform was utilized to generate a substrate growth utilisation profile 355 
for selected S. Enteritidis isolates. Corresponding signal values of replicate pairs of a 356 
Central/Eastern African isolate (D7795) and a global epidemic isolate (A1636) were 357 
compared using principal component analysis and found to be highly consistent. In 358 
total, 80 metabolites showed evidence of differential metabolic activity (Figure 3). 359 
Evaluation of data from the Central/Eastern African isolate using Pathway Tools 360 
software revealed that 14/27 (52%) of pathways with evidence of decreased 361 
metabolic activity at 28˚C had a corresponding component of genomic degradation. 362 
This was also true for 12/30 (40%) of pathways with evidence of decreased 363 
metabolic activity at 37oC.  364 
 365 
Instances of reduced metabolic activity in a Central/Eastern African strain (D7795) 366 
compared to a global epidemic strain (A1636) included dulcitol and glycolic acid in 367 
the glycerol degradation pathway, propionic acid in the propanediol pathway and 368 
ethylamine and ethanolamine. These are all vitamin B12 (cobalamin) dependent 369 
reactions, for which there was a corresponding signature of genomic degradation. 370 
Also there was reduced activity in response to three forms of butyric acid, alloxan 371 
and allantoic acid metabolism. Allantoin can be found in the serum of birds, but not 372 
humans and is utilised as a carbon source during S. Enteritidis infection of 373 
chickens38, and HDGs relating to allantoin have been noted in S. Typhimurium 374 
ST31313. The full list of differences is detailed in Supplementary Table 6 and 7. This 375 
is a further sign of decreased metabolism of the Central/Eastern African isolate in 376 
the anaerobic environment of the gut.  377 
 378 
Chick infection model suggests divide in host range  379 
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 380 
Given the phenotypic differences observed in the genotypically distinct global and 381 
African clades, we hypothesized that these lineages could have differing infection 382 
phenotypes in an in vivo challenge model. We compared the infection profile of a 383 
member of the Central/Eastern African clade (D7795) to the reference global 384 
epidemic strain P125109 in an avian host. The chicken group infected with P125109 385 
showed mild hepatosplenomegaly consistent with infection by this Salmonella 386 
serovar and cecal colonization (Figure 4A-C). In contrast, the Central/Eastern 387 
African strain displayed significantly reduced invasion at 7 dpi of both liver 388 
(p=0.027) and spleen (p=0.007), however cecal colonization was not significantly 389 
reduced (p=0.160). This is in marked contrast to the behavior of S. Typhimurium 390 
ST313, which is more invasive in a chick infection model12.  391 
 392 
 393 
Discussion 394 
 395 
S. Enteritidis is an example of a successful Salmonella lineage with the apparent 396 
ability to adapt to different hosts and transmission niches as and when 397 
opportunities for specialization have presented. Langridge et al recently evaluated 398 
the Enteritidis/Gallinarum/Dublin lineage of Salmonella, revealing components of 399 
the nature and order of events associated with host-range and restriction39. In the 400 
present study, we have highlighted the plasticity of S. Enteritidis, providing evidence 401 
of three distinct epidemics of human disease. In addition we show multiple 402 
additional clades and clusters that demonstrate the huge reservoir of diversity 403 
amongst S. Enteritidis from which future epidemics might emerge.  404 
 405 
An important question posed by this study is why have distinct clades of Salmonella 406 
emerged to become prominent causes of iNTS disease in Africa, from a serotype 407 
normally considered to be weakly invasive? The presence of a highly 408 
immunosuppressed population due to the HIV pandemic is clearly a key host factor 409 
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that facilitates the clinical syndrome iNTS disease40,41. In addition to human host 410 
factors, there are two distinct African epidemic lineages that have emerged in the 411 
last 90 years. Both lineages are significantly associated with a novel prophage 412 
repertoire, an expanded, MDR-augmented virulence plasmid, and patterns of 413 
genomic degradation with similarity to other host-restricted invasive Salmonella 414 
serotypes including S. Typhi and S. Gallinarum and to clades of S. Typhimurium 415 
associated with invasive disease in Africa13,32,35. This pattern of genomic 416 
degradation is concentrated in pathways specifically associated with an enteric 417 
lifestyle, however it is noteworthy that in the chick infection model, the African S. 418 
Enteritidis invaded the chick liver and spleen less well than the global pandemic 419 
clade. This raises the possibility that the two clades occupy different ecological 420 
niches outside the human host or that they behave differently within the human 421 
host and screening of the huge S. Enteritidis collection from routine Salmonella 422 
surveillance by PHE supports the assertion that these lineages are geographically 423 
restricted to Africa. This study therefore indicates a need to understand what these 424 
ecological niches might be, and then to define the transmission pathways of African 425 
clades of S. Enteritidis, in order to facilitate public health interventions to prevent 426 
iNTS disease. 427 
 428 
The evolution of the S. Enteritidis virulence plasmid is intriguing; pSENV is the 429 
smallest of the known Salmonella virulence-associated plasmids, but in SSA, the 430 
plasmid has nearly doubled in size partly through the acquisition of AMR genes. The 431 
absence of tra genes necessary for conjugal transfer either indicates that MDR status 432 
has evolved through acquisition of MGEs multiple times or through clonal expansion 433 
and vertical transmission of the plasmid to progeny. The available data suggest that 434 
the former scenario has happened twice, once in West Africa, and once in 435 
Central/Eastern Africa.  436 
 437 
Despite S. Enteritidis being reported as a common cause of bloodstream infection 438 
(BSI) in Africa6,7 the Global Enteric Multicenter Study (GEMS) found that Salmonella 439 
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serotypes were an uncommon cause of moderate to severe diarrhoea in African 440 
children less than 5-years of age42. Our data associating the African lineages with 441 
invasive disease is also consistent with data presented in a recent Kenyan study 442 
comparing a limited number and diversity of S. Enteritidis isolates from blood and 443 
stool. Applying the lineages defined in this study to the genome data reported from 444 
Kenya showed that 20.4% of isolates from that study belonging to the global clade 445 
were associated with invasive disease, whereas 63.2% of the isolates in that study 446 
belonging to our Central/Eastern African clade were associated with invasive 447 
disease43. The remaining isolates were associated with cases of enterocolitis or 448 
asymptomatic carriage, confirming that the Central/Eastern African clade can also 449 
cause enterocolitis. The association of S. Enteritidis clades circulating in sub-450 
Saharan Africa with iNTS disease may reflect the fact that their geographical 451 
distribution permits them to behave as opportunistic invasive pathogens in a setting 452 
where advanced immunosuppressive disease is highly prevalent in human 453 
populations.  454 
 455 
In summary, two clades of S. Enteritidis have emerged in Africa, which have 456 
different phenotypes and genotypes to the strains of S. Enteritidis circulating in the 457 
industrial world. These strains display evidence of changing host adaptation, 458 
different virulence determinants and multi-drug resistance, a parallel situation to 459 
the evolutionary history of S. Typhimurium ST313. They may have different 460 
ecologies and/or host ranges to global strains and have caused epidemics of BSI in 461 
at least three countries in SSA, yet are rarely responsible for disease in South Africa. 462 
An investigation into the environmental reservoirs and transmission of these 463 
pathogens is warranted and urgently required. 464 
 465 
 466 
 467 
URLs: 468 
 469 
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Enterobase: https://enterobase.warwick.ac.uk/ 470 
 471 
Data access: Accession numbers for sequencing data including both raw sequencing 472 
reads and assembled sequences are available in Supplementary Table 1.    473 
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Figures  633 
 634 
Figure 1: Maximum likelihood phylogeny of S. Enteritidis based on 675 isolates 635 
rooted to S. Gallinarum. There are 3 epidemic clades; 2 African epidemic clades and 636 
a global epidemic clade. Scale bar indicates nucleotide substitutions per site.  637 
 638 
Figure 2: Differences in accessory genomes of 4 major clades. Approximate position 639 
of prophages in chromosome is depicted, although prophages are not drawn to scale 640 
 641 
Figure 3: Heat map revealing changes in metabolic activity of Central/Eastern 642 
African clade isolate D7795 when compared to global epidemic isolate A1636 at 28 643 
and 37˚C. The figure also displays whether there are corresponding mutations in 644 
genes related to the affected metabolic pathway. (NSSNP=Non-synonymous single 645 
nucleotide polymorphism, HDG = Hypothetically disrupted gene) 646 
 647 
Figure 4: Salmonella isolation from a chick infection model demonstrates failure of 648 
Central/Eastern African clade isolate to invade chicken spleen (4A) and liver (4B) or 649 
to colonize chicken caeca (4C) at 7 days post infection (dpi) (n=24 at this time point) 650 
compared to the global epidemic clade. Numbers are expressed as colony forming 651 
units (CFU) per gram of tissue 652 
 653 
 654 
 655 
 656 
 657 
 658 
 659 
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Tables 660 
Table 1: Summary of metadata (n) by region in numbers  661 
 662 
 663 
*Multidrug resistant: resistant to ≥3 antimicrobials 664 
†Extended spectrum beta lactamase producing 665 
‡Uruguay strains previously characterised by Betancor 44 666 
  667 
Region Total Site of isolation Antimicrobial resistance 
phenotype 
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Asia 11 5 5 1 0 0 0 0 0 
Europe 61 0 16 24 2 0 0 0 0 
South America 27‡ 3 6 7 8 0 0 0 0 
North Africa 12 9 1 1 9 0 0 2 0 
Sub-Saharan 
Africa 
353 269 22 7 99 64 14
9 
0 3 
Republic of South 
Africa 
131 57 74 0 83 44 4 0 0 
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Table 2: Metadata summarised by clade 668 
 Major 
Clade/cluster 
Site of isolation 
N (%) 
Number (%) of 
antimicrobial 
resistance genes* 
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an
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En
vir
on
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Un
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n 
1-3
 
4-6
 
7-9
 
West African 61 (92) 1 (2) 0 (0) 4 (6) 22 (33) 9 
(14) 
35 (66)
Central/Eastern 
African 
155 
(93) 
7 (4) 0 (0) 5 (3) 0 (0) 11 
(7) 
156 
(93) 
Global epidemic 94 (38) 95 
(38) 
31 (12) 30 
(12) 
243 
(97) 
7 (3) 0 (0) 
Outlier cluster 51 (38) 36 
(27) 
27 (20) 20 
(15) 
128 
(96) 
3 (2) 3 (2) 
 669 
*All isolates contained cryptic aminoglycoside acetyltransferase gene aac(6’)-ly26 670 
 671 
 672 
 673 
 674 
 675 
 676 
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Online Methods 677 
 678 
Bacterial Isolates 679 
 680 
S. Enteritidis isolates were selected on the basis of six factors; date of original 681 
isolation, antimicrobial susceptibility pattern, geographic site of original isolation, 682 
source (human [invasive vs stool], animal or environmental), phage type (where 683 
available), and multilocus variable number tandem repeat (MLVA) type (where 684 
available). S. Enteritidis P125109 (EMBL accession no. AM933172) isolated from a 685 
poultry farm from the UK was used as a reference32. The full metadata are in 686 
Supplementary Table 1. Isolates have been attributed to region according to United 687 
Nations statistical divisions.  688 
 689 
Sequencing, SNP-calling, construction of phylogeny and comparative genomics 690 
 691 
PCR libraries were prepared from 500 ng of DNA as previously described45. Isolates 692 
were sequenced using Illumina GA II, HiSeq 2000 and MiSeq machines (Illumina, 693 
San Diego, CA, USA) and 150 bp paired-end reads were generated.  The strains were 694 
aligned to Salmonella Enteritidis reference genome P125109 using a pipeline 695 
developed in-house at the Wellcome Trust Sanger Institute (WTSI). For each isolate 696 
sequenced, the raw sequence read pairs were split to reduce the overall memory 697 
usage and allow reads to be aligned using more than one CPU. The reads were then 698 
aligned using SMALT, a hashing based sequence aligner. The aligned and unmapped 699 
reads were combined into a single BAM file. Picard was used to identify and flag 700 
optical duplicates generated during the making of a standard Illumina library, which 701 
reduces possible effects of PCR bias. All of the alignments were created in a 702 
standardized manner, with the commands and parameters stored in the header of 703 
each BAM file, allowing for the results to be easily reproduced.  704 
 705 
The combined BAM file for each isolate was used as input data in the SAMtools 706 
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mpileup program to call SNPs and small indels, producing a BCF file describing all of 707 
the variant base positions46. A pseudo-genome was constructed by substituting the 708 
base call at each variant or non-variant site, defined in the BCF file, in the reference 709 
genome. Only base calls with a depth of coverage >4 or quality >50 were considered 710 
in this analysis. Base calls in the BCF file failing this quality control filter were 711 
replaced with the "N” character in the pseudo-genome sequence.  712 
  713 
All of the software developed is freely available for download from GitHub under an 714 
open source license, GNU GPL 3.  715 
 716 
Phylogenetic modelling was based on the assumption of a single common ancestor, 717 
therefore variable regions where horizontal genetic transfer occurs were 718 
excluded47,48. A maximum likelihood (ML) phylogenetic tree was then built from the 719 
alignments of the isolates using RAxML (version 7.0.4) using a GTR+I+G model49. 720 
The maximum-likelihood phylogeny was supported by 100 bootstrap pseudo-721 
replicate analyses of the alignment data. Clades were predicted using Hierarchical 722 
Bayesian Analysis of Population Structure (HierBAPS)24. This process was repeated 723 
to construct the plasmid phylogeny, using reads that aligned to pSENV.   724 
To ascertain the presence of the clusters defined by HierBAPs in the Public Health 725 
England (PHE) routine Salmonella surveillance collection, seventeen isolates 726 
representing the diversity of the collection were compared against 2986 S. 727 
Enteritidis PHE genomes.  Single linkage SNP clustering was performed as 728 
previously described50.  A maximum-likelihood phylogeny showing the integration 729 
of the seventeen isolates with 50-SNP cluster representatives of the PHE S. 730 
Enteritidis collection was constructed as above.  FASTQ reads from all PHE 731 
sequences in this study can be found at the PHE Pathogens BioProject at the 732 
National Center for Biotechnology Information (Accession PRJNA248792). 733 
 734 
Temporal reconstruction was performed using Bayesian Evolutionary Analysis 735 
Sampling Trees (BEAST version 1.8.2)51. A relaxed lognormal clock model was 736 
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initially employed. The results of this model indicated that a constant clock model 737 
was not appropriate, as the posterior of the standard deviation of the clock rate did 738 
not include zero. A range of biologically plausible population models (constant, 739 
exponential and skyline) was investigated. Skyline models can be biased by non-740 
uniform sampling and we observed a strong similarity between reconstructed 741 
skyline population and the histogram of sampling dates and so this model was 742 
excluded. The exponential models consistently failed to converge and were 743 
excluded. Thus, for all datasets, lognormal clock and constant population size 744 
models were used. The computational expense required for this analysis precluded 745 
running estimators for model selection. However, we note that Deng et al used the 746 
same models in their analysis of 125 S. Enteritidis isolates. Default priors were used 747 
except for ucld.mean, Gamma(0.001,1000), initial: 0.0001; exponential.popSize, 748 
LogNormal(10,1.5), initial: 121.  749 
 750 
Three chains of 100 million states were run in parallel for each clade of the four 751 
major HierBAPS clades, as well as a fourth chain without genomic data to examine 752 
the influence of the prior, which in all cases was uninformative. The final results, as 753 
used here, all had effective sample sizes (ESS) of over 200 and had convergence 754 
between all three runs. For the Global and Global Outlier lineages, the datasets were 755 
not computationally feasible to analyse. We thus created 3 further random subsets 756 
of the data by drawing n isolates from each sampled year where n was sampled 757 
from a Poisson distribution where λ=2. The posteriors of all subsets were extremely 758 
similar and runs were combined to produce the final most recent common ancestor 759 
(MRCA) estimates. 760 
 761 
In order to gain a detailed insight into genomic differences, a single high quality 762 
sequence from Malawian S. Enteritidis isolate D7795 was aligned against the 763 
P125109 using ABACAS and annotated52. Differences were manually curated against 764 
the reference using the Artemis Comparison Tool (ACT)53. Sections of contigs which 765 
were incorporated into the alignment, but which did not align with P125109 were 766 
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manually inspected and compared to the public databases using BLASTn. When 767 
these regions appeared to be novel prophages, they were annotated using the phage 768 
search tool PHAST and manually curated54. In order to investigate whether the SNPs 769 
and/or indels that were predicted to be responsible for pseudogene formation in 770 
D7795 were distinct to that isolate or conserved across both African epidemic 771 
clades, all isolates were aligned to P12509 and the relevant SNPs/indels 772 
investigated using in-silico PCR of the aligned sequences. Manual curation was 773 
performed to confirm the nature of all pseudogene-associated SNPs/indels. NS-SNPs 774 
identified in D7795 were sorted throughout the African clades by extracting and 775 
aligning the appropriate gene sequences from P125109 and D7795. The coordinates 776 
of the NS-SNPs were then used to identify the relevant sequence and determine the 777 
nature of the base.  778 
 779 
Accessory genome 780 
The pangenome for the dataset was predicted using ROARY 55. Genes were 781 
considered to be core to S. Enteritidis if present in ≥90% of isolates. A relaxed 782 
definition of core genome was used as assemblies were used to generate it and the 783 
more assemblies one uses, the more likely it is that a core gene will be missed in one 784 
sample due to an assembly error. The remaining genes were considered to be core 785 
to the clades/clusters predicted by HierBAPS if present in ≥75% if isolates from 786 
within each clade/cluster. These genes were then curated manually using ACT to 787 
search for their presence and position in P125109 or the improved draft assembly 788 
of representative isolates of each of the other clades if not present in P125109. Any 789 
large accessory regions identified were blasted against the assembled genomes of 790 
the entire collection to confirm they were grossly intact. 791 
 792 
Plasmid identification  793 
Plasmid DNA was extracted from isolate D7795 using the Kado & Liu method and 794 
separated by gel-electrophoresis alongside plasmids of known size, to estimate the 795 
number and size of plasmids present56. Plasmid conjugation was attempted by 796 
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mixing 100 μL of overnight culture of donor and recipient strains (rifampicin 797 
resistant Escherichia coli C600) on Luria-Bertani agar plates and incubating 798 
overnight at 26°C and 37°C. The plasmid was sequenced using the PacBio platform 799 
to gain long reads and a single improved draft assembly, which was aligned against 800 
P125109 plasmid pSENV (Accession Number HG970000). For novel regions of the 801 
plasmid from isolate D7795, genes were predicted using GLIMMER and manual 802 
annotations applied based on homology searches against the public databases, using 803 
both BLASTn and FASTA. The plasmid phylogeny was reconstructed using the same 804 
methodology as the chromosome; a maximum likelihood (ML) phylogenetic tree 805 
was built from the alignments of the isolates using RAxML (version 7.0.4) using a 806 
GTR+I+G model 807 
 808 
Identification of AMR genes 809 
 810 
A manually curated version of the Resfinder database was used to investigate the 811 
isolates for the presence of AMR genes57. To reduce redundancy, the database was 812 
clustered using CD-HIT-EST58, with the alignment length of the shorter sequence 813 
required to be 90% the length of the longer sequence. All other options were left as 814 
the defaults. The representative gene of each cluster was then mapped with SMALT 815 
to the assemblies of each isolate to identify and matches with an identity of 90% or 816 
greater were considered significant, in line with the default clustering parameters of 817 
CD-HIT-EST. Where partial matches were identified at the ends of contigs, having an 818 
identity of 90% or greater to the matched region of the gene, potential AMR gene 819 
presence was recorded. To confirm presence of these partial matches, raw 820 
sequencing reads of the pertinent isolates were mapped using SMALT to these genes 821 
to check for 90% identity across the entire gene. 822 
 823 
BiologTM growth substrate platform profiling 824 
 825 
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The BiologTM platform enables the simultaneous quantitative measurement of a 826 
number of cellular phenotypes, and therefore the creation of a phenotypic profile of 827 
a variety of assay conditions59. Incubation and recording of phenotypic data were 828 
performed using an OmniLog® plate reader.  829 
 830 
In these experiments, two replicates of D7795 were compared to two replicates of a 831 
PT4 like strain at 28˚C and 37˚C to represent environmental and human 832 
temperatures. BiologTM plates PM1-4 and 9 (Carbon source [PM1,PM2], nitrogen 833 
source [PM3] and phosphor and sulphur source [PM4] metabolism and osmotic 834 
pressure [PM9]) were used. Each well was inoculated as described below, thereby 835 
testing 475 conditions at once (each plate has one negative control well).  836 
 837 
The isolates were cultured overnight on LB-agar at 37oC in air to exclude 838 
contamination. Colonies were scraped off plates and dispensed into IF-0a solution 839 
(Biolog) to a cell density corresponding to 81% transmittance. For each plate used, 840 
880 µL of this cell suspension was added to 10 mL IF-10b GP/GP solution (Biolog) 841 
and 120 µL dye mix G (Biolog). This was then supplemented with a 1 mL solution of 842 
7.5 mM D-ribose (Sigma), 2 mM magnesium chloride, 1 mM calcium chloride, 2 mM 843 
sodium pyrophosphate (Sigma), 25 µM L-arginine (Sigma), 25 µM L-methionine 844 
(Sigma), 25 µM hypoxanthine (Sigma), 10 µM lipoamide (Sigma), 5 µM nicotine 845 
adenine dinucleotide (Sigma), 0.25 µM riboflavin (Sigma), 0.005% by mass yeast 846 
extract (Fluka) and 0.005% by mass Tween 80 (Sigma). 100µl of this mixture was 847 
dispensed into each well on the assay plate. Plates were then allowed to equilibrate 848 
in air for 5 min prior to being sealed in airtight bags and loaded into the Omnilog 849 
machine (Biolog). Plates were scanned every 15 min for 48 hours while incubated at 850 
28°C and 37°C in air. Culture under anaerobic conditions was unavailable. Two 851 
paired replicates were performed for each of the two isolates. 852 
After completion of the run, the signal data were compiled and analysed using the 853 
limma package in ‘R’ described previously60. A log-fold change of 0.5 controlling for 854 
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a 5% false discovery rate was used as a cut-off for investigating a specific metabolite 855 
further using Pathway Tools61 and whether the metabolic change was related to 856 
pseudogenes and non synonymous(NS)-SNPs in genes in the respective genomes. 857 
 858 
In vivo Infection Model 859 
 860 
Two isolates were used in the animal models: S. Enteritidis P125109 and D7795. 861 
Unvaccinated commercial female egg-layer Lohmann Brown chicks (Domestic Fowl 862 
[Gallus gallus]) were obtained from a commercial hatchery and housed in secure 863 
floor pens at a temperature of 25°C. Eight chicks per strain per time point were 864 
inoculated by gavage at 10 days (d) of age and received a dose of ~108 Salmonella 865 
colony forming units (CFU) in a volume of 0.2 mL. Subsequently, four to five birds 866 
from each group were humanely killed at 3, 7 or 21 d post-infection (p.i.). At post 867 
mortem, the liver, spleen, and caecal contents were removed aseptically, 868 
homogenised, serially diluted and dispensed onto Brilliant Green agar (Oxoid) to 869 
quantify colony forming units (CFU) as described previously62. Statistical analysis 870 
was performed using SPSS, version 20 (IBM). Kruskal-Wallis was used to compare 871 
bacterial loads between infected groups. 872 
 873 
All work was conducted in accordance with the UK legislation governing 874 
experimental animals, Animals (Scientific Procedures) Act 1986, under project 875 
licence 40/3652 and was approved by the University of Liverpool ethical review 876 
process prior to the award of the project license.   The licensing procedure requires 877 
power calculations to determine minimal group sizes for each procedure to ensure 878 
results are significant. For these experiments a group size of 8 birds per time point 879 
was chosen, based on a variation in 1.0 log10 in bacterial count between groups as 880 
being significant along with prior experience of Salmonella infection studies. Groups 881 
were randomly selected on receipt from the hatchery and investigators conducting 882 
animal experiments were not blinded, as the current UK code of practice requires all 883 
cages or pens to be fully labeled with experimental details. No animals were 884 
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excluded from the analysis.  All animals were checked a minimum of twice daily to 885 
ensure their health and welfare. 886 
 887 
Code availability & URLs  888 
 889 
Software is referenced and URLS are provided below. All software is open source.  890 
 891 
BEAST: http://beast.bio.ed.ac.uk/ 892 
BiologTM: http://www.biolog.com 893 
BLASTn: http://blast.ncbi.nlm.nih.gov 894 
limma package: www.bioconductor.org 895 
PacBio platform: http://www.pacificbiosciences.com/ 896 
Picard: https://broadinstitute.github.io/picard 897 
‘R’: www.R-project.org 898 
SMALT: www.sanger.ac.uk/science/tools/smalt-0 899 
United Nations statistical divisions: 900 
www.unstats.un.org/unsd/methods/m49/m49regin.htm  901 
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